POLYPHOR – INNOVATION IN DRUG DISCOVERY

Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.


These macrocycles represent a new drug class complementary to the classical small molecules and large biopharmaceuticals.


Our proprietary and unique technologies are broadly applicable to a wide array of biological targets and disease areas and provide innovative treatment options.


We leverage our technologies to develop our own product portfolio and to pursue licensing and collaboration opportunities.

News

September 14-15, 2017 - World Anti-Microbial Resistance Congress USA 2017 

July 18, 2017 - Polyphor achieves ahead of schedule first milestone from Wellcome Trust...

July 10, 2017 - "Polyphor contributes to the progress in understanding Neutrophil Elastase Science"

July 6-8, 2017 - 2nd World Bronchiectasis Conference

 

 

 

 

 

 


Polyphor Ltd
Hegenheimermattweg 125
CH-4123 Allschwil
Switzerland
Tel. +41 61 567 16 00
Fax +41 61 567 16 01
info@polyphor.com

Last modified:   18.07.2017